CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim

Cancer Research and Treatment. 2018;50(2):488-494. Published online 2017 May 22 DOI: https://doi.org/10.4143/crt.2016.584

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae-Lyun Lee, Se-Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim

Cancer Research and Treatment. 2018;50(2):488-494

Link1

Link2 Link3

A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial

Anjali Zarkar, Sarah Pirrie, Clive Stubbs, Anne-Marie Hodgkins, David Farrugia, Kathryn Fife, Carey MacDonald-Smith, Naveen Vasudev, Emilio Porfiri

Clinical Genitourinary Cancer. 2022;

Link1 Link2

Treatment for Non-clear Cell Renal Cell Carcinoma

Makoto Sumitomo

Renal Cell Carcinoma. 2017;319-332

Link1

A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non–clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus

Inkeun Park, Se Hoon Lee, Jae Lyun Lee

Clinical Genitourinary Cancer. 2018;16(5):e997-e1002

Link1 Link2

A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma

Thomas E. Hutson, M. Dror Michaelson, Timothy M. Kuzel, Neeraj Agarwal, Ana M. Molina, James J. Hsieh, Ulka N. Vaishampayan, Ran Xie, Urmi Bapat, Weifei Ye, Rohit K. Jain, Mayer N. Fishman

European Urology. 2021;80(2):162-170

Link1 Link2

740 CAMRELIZUMAB IN COMBINATION WITH PREOPERATIVE CHEMOTHERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY

Feng Wang, Yu Qi, Xiangrui Meng, Qingxia Fan

Diseases of the Esophagus. 2021;34(Supplement_1):

Link1

Link2

Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study

David R. Spigel, David M. Waterhouse, Steve Lane, Philippe Legenne, Kamal Bhatt

Clinical Lung Cancer. 2013;14(4):356-363

Link1 Link2

Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study

John A. Thompson, Timothy Kuzel, Beverly J. Drucker, Walter J. Urba, Ronald M. Bukowski

Clinical Genitourinary Cancer. 2009;7(3):E58-E65

Link1 Link2

<p>Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study</p>

Zhiwei Chen, Shengping Shen, Wenbo Shi, Gening Jiang, Xin Wang, Hong Jian, Zhen Zhou, Zhengping Ding, Shun Lu

Cancer Management and Research. 2019;Volume 11:6543-6552

Link1 Link2

Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of metastatic renal cell carcinoma (SWITCH-II)

M. Retz, J. Bedke, E. Herrmann, M-O. Grimm, U. Zimmermann, L. Müller, C. Leiber, D. Teber, M. Wirth, C. Bolenz, R. van Alphen, M. De Santis, A. Beeker, M. Frank, J.E. Gschwend

Annals of Oncology. 2017;28:v295

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.